Insights

NZX revenue growth comparison

Revenue growth rates across covered NZX companies, ranked by each company's latest reported period.

Last updated 2 July 2026

Revenue growth trend

Reported revenue growth across covered companies; base-effect moves above 500% are omitted from the chart.

Loading chart...

FY21 AFC: Outside range low revenue growth. -47.6%; 4-period range -44% to 159%. Revenue growth: -47.6%, below normal range; 4-period mean 25.6%, range -44.0%-159.0%.
FY23 AFC: Unprecedented high revenue growth. 159%; 4-period range -47.6% to 23.2%. Revenue growth: 159.0%, unprecedented high; 4-period mean -26.1%, range -47.6%-23.2%.
HY23 AIR: Outside range high revenue growth. 173.6%; 3-period range -2% to 11.2%. Revenue growth: 173.6%, above normal range; 3-period mean 3.5%, range -2.0%-11.2%.
FY23 AIR: Outside range high revenue growth. 131.5%; 3-period range 0% to 8.6%. Revenue growth: 131.5%, above normal range; 3-period mean 5.1%, range 0.0%-8.6%.
HY25 AIR: Outside range low revenue growth. -2%; 3-period range 1.2% to 173.6%. Revenue growth: -2.0%, below normal range; 3-period mean 62.0%, range 1.2%-173.6%.
FY25 AIR: Outside range low revenue growth. 0%; 3-period range 6.7% to 131.5%. Revenue growth: 0.0%, below normal range; 3-period mean 48.9%, range 6.7%-131.5%.
FY20 AOF: Outside range low revenue growth. -40.2%; 3-period range 5% to 74.1%. Revenue growth: -40.2%, below normal range; 3-period mean 31.6%, range 5.0%-74.1%.
FY21 AOF: Outside range high revenue growth. 74.1%; 3-period range -40.2% to 15.7%. Revenue growth: 74.1%, above normal range; 3-period mean -6.5%, range -40.2%-15.7%.
HY22 ARB: Outside range low revenue growth. -61.3%; 3-period range 7.6% to 78.4%. Revenue growth: -61.3%, below normal range; 3-period mean 49.0%, range 7.6%-78.4%.
HY24 ARB: Outside range high revenue growth. 78.4%; 3-period range -61.3% to 60.9%. Revenue growth: 78.4%, above normal range; 3-period mean 2.4%, range -61.3%-60.9%.
FY25 ARB: Outside range low revenue growth. -6.6%; 3-period range 7.9% to n/m. Revenue growth: -6.6%, below normal range; 3-period mean 382.7%, range 7.9%n/m.
FY21 ARG: Outside range high revenue growth. 6.9%; 5-period range -50.7% to 3.3%. Revenue growth: 6.9%, above normal range; 5-period mean -26.8%, range -50.7%-3.3%.
FY22 ARG: Outside range low revenue growth. -50.7%; 5-period range -49.9% to 6.9%. Revenue growth: -50.7%, below normal range; 5-period mean -15.3%, range -49.9%-6.9%.
FY23 APL: Unprecedented low revenue growth. -46.6%; 4-period range -16.4% to 27.9%. Revenue growth: -46.6%, unprecedented low; 4-period mean -1.6%, range -16.4%-27.9%.
HY24 APL: Outside range low revenue growth. -39.7%; 3-period range -33.4% to 24%. Revenue growth: -39.7%, below normal range; 3-period mean -3.5%, range -33.4%-24.0%.
HY25 APL: Outside range high revenue growth. 24%; 3-period range -39.7% to -1.2%. Revenue growth: 24.0%, above normal range; 3-period mean -24.7%, range -39.7%--1.2%.
FY25 APL: Unprecedented high revenue growth. 27.9%; 4-period range -46.6% to -3.8%. Revenue growth: 27.9%, unprecedented high; 4-period mean -20.2%, range -46.6%--3.8%.
FY21 AIA: Unprecedented low revenue growth. -50.4%; 4-period range 6.8% to 108.4%. Revenue growth: -50.4%, unprecedented low; 4-period mean 42.6%, range 6.8%-108.4%.
HY22 AIA: Outside range low revenue growth. -4%; 4-period range 3.9% to 128.1%. Revenue growth: -4.0%, below normal range; 4-period mean 49.7%, range 3.9%-128.1%.
HY23 AIA: Unprecedented high revenue growth. 128.1%; 4-period range -4% to 53.1%. Revenue growth: 128.1%, unprecedented high; 4-period mean 16.6%, range -4.0%-53.1%.
FY23 AIA: Unprecedented high revenue growth. 108.4%; 4-period range -50.4% to 43.1%. Revenue growth: 108.4%, unprecedented high; 4-period mean 2.9%, range -50.4%-43.1%.
HY22 AFI: Unprecedented high revenue growth. 68.1%; 4-period range -5.4% to 10.1%. Revenue growth: 68.1%, unprecedented high; 4-period mean 1.2%, range -5.4%-10.1%.
HY24 AFI: Outside range low revenue growth. -5.4%; 4-period range -2.8% to 68.1%. Revenue growth: -5.4%, below normal range; 4-period mean 19.6%, range -2.8%-68.1%.
FY22 BRM: Outside range low revenue growth. -93.4%; 4-period range 4.4% to n/m. Revenue growth: -93.4%, below normal range; 4-period mean 449.3%, range 4.4%n/m.
HY23 BLT: Outside range low revenue growth. 10.2%; 3-period range 11.4% to 28.1%. Revenue growth: 10.2%, below normal range; 3-period mean 21.6%, range 11.4%-28.1%.
FY25 BLT: Outside range low revenue growth. 9.7%; 3-period range 12.6% to 16%. Revenue growth: 9.7%, below normal range; 3-period mean 14.3%, range 12.6%-16.0%.
HY26 BLT: Outside range high revenue growth. 28.1%; 3-period range 10.2% to 25.4%. Revenue growth: 28.1%, above normal range; 3-period mean 15.7%, range 10.2%-25.4%.
FY26 BLT: Outside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.
FY25 BRW: Outside range high revenue growth. 10.7%; 4-period range -49.7% to -3.2%. Revenue growth: 10.7%, above normal range; 4-period mean -19.4%, range -49.7%--3.2%.
FY26 BRW: Unprecedented low revenue growth. -49.7%; 4-period range -14.4% to 10.7%. Revenue growth: -49.7%, unprecedented low; 4-period mean -4.3%, range -14.4%-10.7%.
HY22 BGP: Outside range high revenue growth. 22.6%; 3-period range 0% to 2.7%. Revenue growth: 22.6%, above normal range; 3-period mean 1.3%, range 0.0%-2.7%.
FY22 BGP: Outside range high revenue growth. 6.1%; 4-period range -0.1% to 5.6%. Revenue growth: 6.1%, above normal range; 4-period mean 1.8%, range -0.1%-5.6%.
FY25 BGP: Outside range low revenue growth. -0.1%; 4-period range 0.8% to 6.1%. Revenue growth: -0.1%, below normal range; 4-period mean 3.3%, range 0.8%-6.1%.
HY26 BGP: Outside range low revenue growth. 0%; 3-period range 1.1% to 22.6%. Revenue growth: 0.0%, below normal range; 3-period mean 8.8%, range 1.1%-22.6%.
HY22 BFG: Outside range high revenue growth. 16%; 4-period range -1.3% to 15.9%. Revenue growth: 16.0%, above normal range; 4-period mean 3.5%, range -1.3%-15.9%.
HY25 BFG: Outside range low revenue growth. -1.3%; 4-period range -0.6% to 16%. Revenue growth: -1.3%, below normal range; 4-period mean 7.8%, range -0.6%-16.0%.
HY23 CDI: Outside range low revenue growth. -75.1%; 3-period range -22.2% to 40.3%. Revenue growth: -75.1%, below normal range; 3-period mean 0.3%, range -22.2%-40.3%.
FY23 CDI: Outside range low revenue growth. -54.1%; 4-period range -27% to 59.4%. Revenue growth: -54.1%, below normal range; 4-period mean 3.4%, range -27.0%-59.4%.
HY24 CDI: Outside range high revenue growth. 40.3%; 3-period range -75.1% to -17.2%. Revenue growth: 40.3%, above normal range; 3-period mean -38.2%, range -75.1%--17.2%.
FY24 CDI: Unprecedented high revenue growth. 59.4%; 4-period range -54.1% to 3.7%. Revenue growth: 59.4%, unprecedented high; 4-period mean -24.9%, range -54.1%-3.7%.
HY22 CHI: Outside range low revenue growth. -74.1%; 3-period range 0.5% to 115.9%. Revenue growth: -74.1%, below normal range; 3-period mean 41.6%, range 0.5%-115.9%.
FY22 CHI: Unprecedented low revenue growth. -61.9%; 4-period range -0.9% to 48.1%. Revenue growth: -61.9%, unprecedented low; 4-period mean 13.6%, range -0.9%-48.1%.
HY23 CHI: Outside range high revenue growth. 115.9%; 3-period range -74.1% to 8.4%. Revenue growth: 115.9%, above normal range; 3-period mean -21.7%, range -74.1%-8.4%.
FY23 CHI: Unprecedented high revenue growth. 48.1%; 4-period range -61.9% to 7%. Revenue growth: 48.1%, unprecedented high; 4-period mean -13.9%, range -61.9%-7.0%.
HY23 CNU: Outside range low revenue growth. 0.8%; 3-period range 1.2% to 141.8%. Revenue growth: 0.8%, below normal range; 3-period mean 49.0%, range 1.2%-141.8%.
HY24 CNU: Outside range high revenue growth. 141.8%; 3-period range 0.8% to 4%. Revenue growth: 141.8%, above normal range; 3-period mean 2.0%, range 0.8%-4.0%.
HY23 CEN: Outside range low revenue growth. -12.7%; 3-period range -5.3% to 31.4%. Revenue growth: -12.7%, below normal range; 3-period mean 18.9%, range -5.3%-31.4%.
HY24 CEN: Outside range high revenue growth. 31.4%; 3-period range -12.7% to 30.7%. Revenue growth: 31.4%, above normal range; 3-period mean 4.2%, range -12.7%-30.7%.
FY22 CCC: Outside range high revenue growth. 283.3%; 3-period range -29.4% to 83.7%. Revenue growth: 283.3%, above normal range; 3-period mean 18.3%, range -29.4%-83.7%.
FY24 CCC: Outside range low revenue growth. -29.4%; 3-period range 0.7% to 283.3%. Revenue growth: -29.4%, below normal range; 3-period mean 122.6%, range 0.7%-283.3%.
FY23 ERD: Outside range high revenue growth. 52.2%; 3-period range 0.4% to 6.8%. Revenue growth: 52.2%, above normal range; 3-period mean 3.8%, range 0.4%-6.8%.
FY26 ERD: Outside range low revenue growth. 0.4%; 3-period range 4.1% to 52.2%. Revenue growth: 0.4%, below normal range; 3-period mean 21.0%, range 4.1%-52.2%.
HY23 FPH: Outside range low revenue growth. -23.3%; 3-period range 14.4% to 18.4%. Revenue growth: -23.3%, below normal range; 3-period mean 16.4%, range 14.4%-18.4%.
HY25 FPH: Outside range high revenue growth. 18.4%; 3-period range -23.3% to 16.4%. Revenue growth: 18.4%, above normal range; 3-period mean 2.5%, range -23.3%-16.4%.
FY21 FBU: Unprecedented high revenue growth. 11.1%; 4-period range -9.3% to 4.7%. Revenue growth: 11.1%, unprecedented high; 4-period mean -3.5%, range -9.3%-4.7%.
HY23 FBU: Outside range high revenue growth. 5.4%; 4-period range -20% to 1.9%. Revenue growth: 5.4%, above normal range; 4-period mean -8.6%, range -20.0%-1.9%.
FY24 FBU: Outside range low revenue growth. -9.3%; 4-period range -9% to 11.1%. Revenue growth: -9.3%, below normal range; 4-period mean 1.6%, range -9.0%-11.1%.
HY26 FBU: Unprecedented low revenue growth. -20%; 4-period range -15.7% to 5.4%. Revenue growth: -20.0%, unprecedented low; 4-period mean -2.3%, range -15.7%-5.4%.
HY23 GEN: Outside range low revenue growth. 4.4%; 3-period range 19% to 38.6%. Revenue growth: 4.4%, below normal range; 3-period mean 30.7%, range 19.0%-38.6%.
HY25 GEN: Outside range high revenue growth. 38.6%; 3-period range 4.4% to 34.6%. Revenue growth: 38.6%, above normal range; 3-period mean 19.3%, range 4.4%-34.6%.
HY23 GXH: Outside range high revenue growth. 14.6%; 3-period range -29.5% to 3.9%. Revenue growth: 14.6%, above normal range; 3-period mean -7.9%, range -29.5%-3.9%.
HY24 GXH: Outside range low revenue growth. -29.5%; 3-period range 1.8% to 14.6%. Revenue growth: -29.5%, below normal range; 3-period mean 6.8%, range 1.8%-14.6%.
FY21 HLG: Unprecedented high revenue growth. 21.9%; 4-period range 0.1% to 16.7%. Revenue growth: 21.9%, unprecedented high; 4-period mean 7.8%, range 0.1%-16.7%.
HY22 HLG: Outside range low revenue growth. -6.2%; 4-period range -0.2% to 30.9%. Revenue growth: -6.2%, below normal range; 4-period mean 13.3%, range -0.2%-30.9%.
FY22 HLG: Unprecedented low revenue growth. 0.1%; 4-period range 6.3% to 21.9%. Revenue growth: 0.1%, unprecedented low; 4-period mean 13.3%, range 6.3%-21.9%.
HY23 HLG: Unprecedented high revenue growth. 30.9%; 4-period range -6.2% to 14.7%. Revenue growth: 30.9%, unprecedented high; 4-period mean 4.0%, range -6.2%-14.7%.
FY22 HGH: Outside range high revenue growth. 11.7%; 3-period range 0.2% to 11.1%. Revenue growth: 11.7%, above normal range; 3-period mean 4.9%, range 0.2%-11.1%.
HY24 HGH: Unprecedented low revenue growth. -2%; 4-period range 8.9% to 11.1%. Revenue growth: -2.0%, unprecedented low; 4-period mean 10.0%, range 8.9%-11.1%.
FY24 HGH: Outside range low revenue growth. 0.2%; 3-period range 3.3% to 11.7%. Revenue growth: 0.2%, below normal range; 3-period mean 8.7%, range 3.3%-11.7%.
HY26 HGH: Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%.

← Swipe to view more

NZX revenue growth comparison table
Company	Ticker	Period	Period type	Revenue	Revenue growth	Prior growth
Barramundi	BRM	HY26	6 months	$13.5m	474.9%	16.2%
Henderson Far East Income	HFL	HY26	6 months	$23.1m	208.4%	-3.1%
Rua Bioscience	RUA	HY26	6 months	$1.3m	92.2%Caveat: basis discontinuity.Outside range high revenue growth. 92.2%; 3-period range -100% to 33.8%. Revenue growth: 92.2%, above normal range; 3-period mean -31.8%, range -100.0%-33.8%.	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cooks Coffee Company	CCC	FY26	12 months	$12.4m	83.7%Caveat: restatement or reclassification, basis discontinuity.	-29.4%Caveat: basis discontinuity.
Scales Corporation	SCL	FY25	12 months	$899.9m	53.9%Caveat: basis discontinuity, transaction distorted.Unprecedented high revenue growth. 53.9%; 4-period range -8.7% to 20.3%. Revenue growth: 53.9%, unprecedented high; 4-period mean 6.1%, range -8.7%-20.3%.	16.9%Caveat: basis discontinuity.
Truscreen Group	TRU	FY26	12 months	$2.4m	42.2%Caveat: insufficient history.	-0.7%
Serko	SKO	FY26	12 months	$119.4m	34.9%Caveat: basis discontinuity, transaction distorted.	47.4%Caveat: basis discontinuity, transaction distorted.
Rakon	RAK	HY26	6 months	$54.2m	30.2%Caveat: basis discontinuity.Outside range high revenue growth. 30.2%; 3-period range -32% to 2%. Revenue growth: 30.2%, above normal range; 3-period mean -19.9%, range -32.0%-2.0%.	-32.0%Caveat: basis discontinuity.
Promisia Healthcare	PHL	FY26	12 months	$40.1m	29.1%Caveat: transaction distorted.	25.6%Caveat: transaction distorted.
Property for Industry	PFI	HY26	6 months	$73.6m	20.2%Caveat: restatement or reclassification, transaction distorted.	170.1%
General Capital	GEN	HY26	6 months	$12.9m	19.0%	31.8%Caveat: basis discontinuity, transaction distorted.
Comvita	CVT	HY26	6 months	$118m	18.3%Caveat: basis discontinuity, insufficient history.	-7.8%Caveat: basis discontinuity.
Third Age Health Services	TAH	FY26	12 months	$22.5m	17.9%Caveat: basis discontinuity, transaction distorted, insufficient history.	94.4%Caveat: basis discontinuity.
South Port New Zealand	SPN	HY26	6 months	$34.8m	17.5%Outside range high revenue growth. 17.5%; 4-period range -0.2% to 16.1%. Revenue growth: 17.5%, above normal range; 4-period mean 6.2%, range -0.2%-16.1%.	12.7%Caveat: basis discontinuity.
BLIS Technologies	BLT	FY26	12 months	$14.7m	16.0%Caveat: basis discontinuity.Outside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.	28.1%Caveat: basis discontinuity.
AoFrio	AOF	FY22	12 months	$74.3m	15.7%Caveat: basis discontinuity.	74.1%Caveat: basis discontinuity.
Hallenstein Glasson	HLG	HY26	6 months	$275.2m	14.7%Caveat: basis discontinuity.	8.1%Caveat: basis discontinuity.
T&G Global Limited and subsidiary companies	TGG	FY25	12 months	$1.6b	14.5%Caveat: basis discontinuity.Unprecedented high revenue growth. 14.5%; 4-period range -4.4% to 2.3%. Revenue growth: 14.5%, unprecedented high; 4-period mean -0.8%, range -4.4%-2.3%.	12.3%Caveat: restatement or reclassification, basis discontinuity.
Fisher & Paykel Healthcare	FPH	FY26	12 months	$2.3b	14.2%Caveat: basis discontinuity, insufficient history.	14.4%Caveat: basis discontinuity.
Radius Residential Care	RAD	FY26	12 months	$200.1m	14.2%Caveat: basis discontinuity, transaction distorted.	19.0%Caveat: basis discontinuity, transaction distorted.
Enprise Group	ENS	FY25	12 months	$24.8m	13.6%Caveat: basis discontinuity, transaction distorted, insufficient history.	21.2%Caveat: basis discontinuity, transaction distorted.
Summerset Group Holdings	SUM	FY25	12 months	$361.8m	13.1%Caveat: basis discontinuity.Outside range low revenue growth. 13.1%; 3-period range 14% to 17.5%. Revenue growth: 13.1%, below normal range; 3-period mean 15.9%, range 14.0%-17.5%.	14.1%Caveat: basis discontinuity, transaction distorted.
EBOS Group	EBO	HY26	6 months	$6.8b	13.0%Caveat: basis discontinuity, insufficient history.	-7.0%Caveat: basis discontinuity, transaction distorted.
Ryman Healthcare	RYM	FY26	12 months	$855.6m	12.5%Caveat: restatement or reclassification, basis discontinuity, insufficient history.	13.0%Caveat: basis discontinuity.
The a2 Milk Company	ATM	HY26	6 months	$992.6m	11.2%Caveat: basis discontinuity, transaction distorted, insufficient history.	13.5%Caveat: basis discontinuity, transaction distorted.
Heartland Group Holdings	HGH	HY26	6 months	$172.3m	11.1%Caveat: basis discontinuity.Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%.	11.1%Caveat: basis discontinuity, transaction distorted.
Skellerup Holdings	SKL	HY26	6 months	$183.5m	11.0%Caveat: basis discontinuity, insufficient history.	6.9%Caveat: basis discontinuity.
Goodman Property Trust	GNZ	HY26	6 months	$148.8m	10.4%Caveat: insufficient history.	13.8%Caveat: transaction distorted.
Vista Group International	VGL	FY25	12 months	$164.3m	9.5%Caveat: basis discontinuity, insufficient history.	10.6%Caveat: basis discontinuity.
Turners Automotive Group	TRA	FY26	12 months	$450.2m	9.0%Caveat: basis discontinuity, transaction distorted.	7.0%Caveat: basis discontinuity, transaction distorted.
The Colonial Motor Company	CMO	HY26	6 months	$552.4m	8.8%Caveat: basis discontinuity.	-1.1%Caveat: basis discontinuity.
Napier Port Holdings	NPH	HY26	6 months	$84.9m	8.7%Caveat: basis discontinuity, transaction distorted.	11.6%Caveat: basis discontinuity.
PGG Wrightson	PGW	HY26	6 months	$619.4m	8.6%Caveat: basis discontinuity, insufficient history.	6.5%Caveat: basis discontinuity.
Port of Tauranga	POT	HY26	6 months	$244.1m	8.5%Caveat: basis discontinuity.	—
Freightways Group	FRW	HY26	6 months	$718.2m	8.5%Caveat: basis discontinuity, transaction distorted, insufficient history.	6.6%Caveat: restatement or reclassification, basis discontinuity.
Fonterra Co-operative Group	FCG	HY26	6 months	$167m	8.4%Caveat: transaction distorted, insufficient history.	-98.6%Caveat: basis discontinuity, transaction distorted.
Steel & Tube Holdings	STU	HY26	6 months	$211.9m	8.1%Caveat: basis discontinuity, transaction distorted, insufficient history.	-19.6%Caveat: basis discontinuity, transaction distorted.
ArborGen Holdings	ARB	FY26	12 months	$68.2m	7.9%Caveat: basis discontinuity.	7.6%Caveat: basis discontinuity.
Sky Network Television	SKT	HY26	6 months	$414.4m	7.7%Caveat: restatement or reclassification, transaction distorted.Unprecedented high revenue growth. 7.7%; 4-period range -2% to 4.1%. Revenue growth: 7.7%, unprecedented high; 4-period mean 1.9%, range -2.0%-4.1%.	-2.1%Caveat: basis discontinuity, transaction distorted.
Burger Fuel Group	BFG	FY26	12 months	$25.6m	7.4%Caveat: basis discontinuity, transaction distorted, insufficient history.	-0.6%Caveat: restatement or reclassification, basis discontinuity.
KMD Brands	KMD	HY26	6 months	$505.4m	7.3%Caveat: basis discontinuity, transaction distorted, insufficient history.	1.0%Caveat: basis discontinuity.
Seeka	SEK	FY25	12 months	$439.6m	6.9%Caveat: basis discontinuity.Outside range low revenue growth. 6.9%; 3-period range 12.5% to 41.5%. Revenue growth: 6.9%, below normal range; 3-period mean 30.2%, range 12.5%-41.5%.	36.7%Caveat: basis discontinuity.
New Zealand King Salmon Investments	NZK	HY26	6 months	$100.3m	6.1%Caveat: basis discontinuity.	-7.1%
Vector	VCT	HY26	6 months	$594.4m	6.1%Caveat: basis discontinuity.	-3.3%Caveat: basis discontinuity.
Millennium & Copthorne Hotels New Zealand	MCK	FY25	12 months	$186.7m	6.0%Caveat: basis discontinuity.	-7.1%Caveat: basis discontinuity.
ikeGPS Group	IKE	FY26	12 months	$26.5m	5.5%Caveat: basis discontinuity, transaction distorted.	5.6%Caveat: basis discontinuity, transaction distorted.
Scott Technology	SCT	HY26	6 months	$128.2m	5.3%Caveat: basis discontinuity.	-0.3%Caveat: basis discontinuity.
Livestock Improvement Corporation	LIC	HY26	6 months	$195.2m	5.2%Caveat: restatement or reclassification, basis discontinuity, insufficient history.	10.4%Caveat: restatement or reclassification, basis discontinuity.
My Food Bag Group	MFB	FY26	12 months	$170.2m	5.0%Outside range high revenue growth. 5%; 4-period range -9.4% to 1.7%. Revenue growth: 5.0%, above normal range; 4-period mean -2.0%, range -9.4%-1.7%.	3.8%Caveat: basis discontinuity.
Westpac Banking Corporation	WBC	HY26	6 months	$11.3b	4.6%	—
Green Cross Health	GXH	FY26	12 months	$546m	4.2%Caveat: basis discontinuity, insufficient history.	1.8%Caveat: basis discontinuity.
Tourism Holdings	THL	HY26	6 months	$477.3m	4.1%Caveat: basis discontinuity, transaction distorted, insufficient history.	1.7%Caveat: basis discontinuity.
Auckland International Airport	AIA	HY26	6 months	$519.6m	3.9%Caveat: basis discontinuity.	12.2%Caveat: basis discontinuity.
Argosy Property	ARG	FY26	12 months	$120.8m	3.3%Caveat: basis discontinuity, transaction distorted.	-49.9%Caveat: basis discontinuity, transaction distorted.
Michael Hill International	MHJ	HY26	6 months	$371m	3.0%Caveat: basis discontinuity.	2.5%Caveat: basis discontinuity.
Kiwi Property Group	KPG	FY26	12 months	$271.4m	2.9%Caveat: basis discontinuity, transaction distorted.	6.5%Caveat: basis discontinuity, transaction distorted.
Mainfreight	MFT	FY26	12 months	$5.4b	2.8%Caveat: basis discontinuity.	11.0%Caveat: basis discontinuity.
Air New Zealand	AIR	HY26	6 months	$3.4b	1.2%	0.0%
Chorus	CNU	HY26	6 months	$506m	1.2%Caveat: basis discontinuity.	0.4%
Briscoe Group	BGP	FY26	12 months	$798.8m	0.9%Caveat: basis discontinuity, transaction distorted.	0.0%Caveat: basis discontinuity.
Precinct Properties	PCT	HY26	6 months	$135.4m	0.7%Caveat: basis discontinuity, transaction distorted.	7.3%Caveat: basis discontinuity, transaction distorted.
Delegat Group	DGL	HY26	6 months	$179.6m	0.5%Caveat: basis discontinuity, insufficient history.	-12.0%Caveat: basis discontinuity.
EROAD	ERD	FY26	12 months	$195.2m	0.4%Caveat: basis discontinuity.Outside range low revenue growth. 0.4%; 3-period range 4.1% to 52.2%. Revenue growth: 0.4%, below normal range; 3-period mean 21.0%, range 4.1%-52.2%.	3.3%Caveat: basis discontinuity.
Channel Infrastructure NZ	CHI	FY25	12 months	$140.2m	0.3%	0.5%
Vulcan Steel	VSL	HY25	6 months	$493m	0.0%Caveat: basis discontinuity.	—
Oceania Healthcare	OCA	HY26	6 months	$131.6m	-0.7%Caveat: basis discontinuity.	-1.8%
NZME	NZM	FY25	12 months	$341.3m	-1.3%Caveat: basis discontinuity, insufficient history.	-2.8%Caveat: basis discontinuity.
Tower	TWR	HY26	6 months	$291.2m	-1.6%Caveat: basis discontinuity.	6.9%Caveat: basis discontinuity.
Gentrack Group Limited 6 months to 31 March 2026	GTK	HY26	6 months	$110.1m	-1.7%Caveat: basis discontinuity, transaction distorted, insufficient history.	8.0%Caveat: basis discontinuity.
Spark New Zealand	SPK	HY26	6 months	$1.9b	-2.4%Caveat: basis discontinuity, transaction distorted.	-3.5%Caveat: basis discontinuity, transaction distorted.
Savor	SVR	FY26	12 months	$55.2m	-2.6%Caveat: basis discontinuity.	-8.4%Caveat: basis discontinuity.
Metro Performance Glass	MPG	FY26	12 months	$208.2m	-2.7%Caveat: basis discontinuity.	-5.3%Caveat: basis discontinuity.
Australian Foundation Investment Company	AFI	HY26	6 months	$168.7m	-2.8%	3.0%
SkyCity Entertainment Group	SKC	HY26	6 months	$406.5m	-3.4%Caveat: basis discontinuity, insufficient history.	-4.6%Caveat: basis discontinuity.
Asset Plus	APL	FY26	12 months	$6.6m	-3.8%Caveat: transaction distorted.	-1.2%Caveat: transaction distorted.
MOVE Logistics Group	MOV	HY26	6 months	$141.4m	-4.7%Caveat: basis discontinuity, insufficient history.	-2.6%Caveat: basis discontinuity.
Mercury NZ	MCY	HY26	6 months	$1.7b	-5.2%Caveat: basis discontinuity.	2.2%
Contact Energy	CEN	HY26	6 months	$1.6b	-5.3%Caveat: basis discontinuity, transaction distorted.	20.1%Caveat: basis discontinuity.
Sanford	SAN	HY26	6 months	$270.2m	-5.5%Caveat: basis discontinuity.	0.2%Caveat: basis discontinuity, transaction distorted.
Infratil	IFT	FY26	12 months	$3b	-10.4%Caveat: basis discontinuity, transaction distorted.	-14.4%Caveat: basis discontinuity, transaction distorted.
Meridian Energy	MEL	HY26	6 months	$2b	-11.0%Caveat: basis discontinuity, transaction distorted.Outside range low revenue growth. -11%; 3-period range -8.6% to 38.1%. Revenue growth: -11.0%, below normal range; 3-period mean 12.1%, range -8.6%-38.1%.	-0.4%Caveat: basis discontinuity.
Genesis Energy	GNE	HY26	6 months	$1.5b	-12.9%Caveat: basis discontinuity.	20.2%Caveat: basis discontinuity.
Synlait Milk	SML	HY26	6 months	$777.6m	-15.2%Caveat: basis discontinuity, transaction distorted.	40.4%Caveat: basis discontinuity.
Marlin Global	MLN	HY26	6 months	$9.4m	-17.2%	—
Templeton Emerging Markets Investment Trust Plc	TEM	HY24	6 months	$45.5m	-19.6%	75.0%
Goodman Property Trust	GMT	FY26	12 months	$223.1m	-19.7%Caveat: basis discontinuity, transaction distorted.	10.4%Caveat: basis discontinuity, transaction distorted.
Fletcher Building	FBU	HY26	6 months	$2.9b	-20.0%Caveat: basis discontinuity.Unprecedented low revenue growth. -20%; 4-period range -15.7% to 5.4%. Revenue growth: -20.0%, unprecedented low; 4-period mean -2.3%, range -15.7%-5.4%.	-9.0%Caveat: basis discontinuity.
CDL Investments New Zealand	CDI	FY25	12 months	$38.1m	-22.3%Caveat: basis discontinuity.	-17.2%Caveat: basis discontinuity.
Me Today	MEE	HY26	6 months	$2.6m	-31.7%Caveat: basis discontinuity, transaction distorted.	48.1%Caveat: basis discontinuity, transaction distorted.
AFC Group Holdings	AFC	FY25	12 months	$0.74m	-44.0%Caveat: basis discontinuity.	-17.8%
Pacific Edge	PEB	HY26	6 months	$5.9m	-45.8%Caveat: insufficient history.	-8.6%Caveat: basis discontinuity, transaction distorted.
The Warehouse Group	WHS	FY25	12 months	$1.6b	-47.1%Caveat: basis discontinuity, insufficient history.	-10.6%Caveat: basis discontinuity.
Bremworth	BRW	FY26	12 months	$44.7m	-49.7%Caveat: basis discontinuity.Unprecedented low revenue growth. -49.7%; 4-period range -14.4% to 10.7%. Revenue growth: -49.7%, unprecedented low; 4-period mean -4.3%, range -14.4%-10.7%.	10.7%
Winton Land	WIN	HY26	6 months	$32.4m	-60.0%Caveat: basis discontinuity, transaction distorted, insufficient history.	-10.4%Caveat: basis discontinuity.
Kingfish	KFL	FY26	12 months	-$8.3m	-179.7%Outside range low revenue growth. -179.7%; 4-period range -106.8% to n/m. Revenue growth: -179.7%, below normal range; 4-period mean 682.5%, range -106.8%n/m.	262.8%
Being AI	BAI	HY24	6 months	$0m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—Caveat: basis discontinuity, transaction distorted.
Blackwell Global Holdings	RTO	HY26	6 months	$0m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.
Iperion	IPR	FY26	12 months	$0m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—Caveat: basis discontinuity.
New Talisman Gold Mines	NTL	FY26	12 months	$0.05m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—Caveat: transaction distorted.
New Zealand Rural Land Company	NZL	HY22	6 months	$4.3m	n/mSuppressed: metric quality flags mark this value as unsuitable for normal comparison.	—

Source: latest published result per company in the current Annolyse coverage set.

NZX revenue growth comparison table

Copy, export, or share this public Annolyse data reference.

Revenue growth is the simplest comparison, but it still needs period context. Half-year results are not directly comparable with full-year absolute revenue, so the useful signal is the growth rate and whether the company is growing from volume, price, acquisitions, or recovery from a weak base.

Methodology

Revenue and revenue growth use standard Annolyse calculations from available filing data. Figures are shown as reported for each company's latest period, and the period-type column distinguishes six-month and twelve-month reporting windows.

Related insights